Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17021
Country/Region: South Africa
Year: 2015
Main Partner: Right to Care
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $14,125,159 Additional Pipeline Funding: $1,750,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $750,000
Care: TB/HIV (HVTB) $2,698,777
Care: Pediatric Care and Support (PDCS) $635,006
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,111,261
Treatment: Adult Treatment (HTXS) $7,025,096
Treatment: Pediatric Treatment (PDTX) $1,905,019
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 11,389
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 7,592
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 584
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 584
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 20,150
CARE_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 20,149
CARE_NEW_DSD Aggregated Age/sex: 15+ Female 2016 3,074
CARE_NEW_DSD Aggregated Age/sex: 15+ Male 2016 2,049
CARE_NEW_DSD Aggregated Age/sex: <15 Female 2016 52
CARE_NEW_DSD Aggregated Age/sex: <15 Male 2016 52
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 5,228
CARE_NEW_DSD Sum of Aggregated Age/sex disaggregates 2016 5,227
CARE_NEW_TA Sum of Aggregated Age/sex disaggregates 2016 5,227
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 7,099
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 12,541
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 577
HTC_TST_DSD By Test Result: Negative 2016 20,217
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 44,585
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2016 19,640
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2016 577
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2016 20,217
HTC_TST_DSD Sum of Test Result disaggregates 2016 20,217
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 789
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 1,393
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 64
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 434,710
HTC_TST_TA Sum of Aggregated Age/Sex 15+ 2016 2,182
HTC_TST_TA Sum of Aggregated Age/Sex <15 2016 64
HTC_TST_TA Sum of Aggregated Age/Sex disaggregates 2016 2,246
PMTCT_ARV_TA Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 21,484
PMTCT_ARV_TA Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 21,059
PMTCT_STAT_TA Number of new ANC and L&D clients 2016 80,474
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 80,474
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 584
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 467
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2016 20,553
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2016 13,704
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 36,367
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2016 34,257
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 34,257
TX_CURR_TA Aggregated Age/Sex: 15+ Female 2016 166,907
TX_CURR_TA Aggregated Age/Sex: 15+ Male 2016 111,865
TX_CURR_TA Number of adults and children receiving antiretroviral therapy (ART) 2016 296,260
TX_CURR_TA Sum of Aggregated Age/Sex 15+ 2016 278,772
TX_CURR_TA Sum of Aggregated Age/Sex disaggregates 2016 278,772
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2016 2,671
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2016 1,780
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 4,685
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2016 4,451
Cross Cutting Budget Categories and Known Amounts Total: $187,035
Motor Vehicles: Purchased $29,839
Human Resources for Health $157,196